|
2022
|
Invention
|
Antibodies against candida albicans proteins and their therapeutic and prophylactic use for treat... |
|
|
Invention
|
Recombinant proteinaceous binding molecules. The present invention relates to a recombinant prote... |
|
|
Invention
|
Novel tnfr2 binding molecules. The present disclosure provides a binding molecule that specifical... |
|
2021
|
Invention
|
Anti-gdf15 antibody and a dosage regimen for the treatment of cancer. The present invention relat... |
|
|
Invention
|
Siglec-6-binding polypeptides. The present invention relates to a siglec-6-binding polypeptide th... |
|
|
Invention
|
Combination therapy of atra or other retinoids with immunotherapeutic agents binding to bcma. The... |
|
|
Invention
|
Affinity matured and humanized binding domains targeting ror2. The invention relates to antibodie... |
|
|
Invention
|
Rna detection and transcription-dependent editing with reprogrammed tracrrnas. The present invent... |
|
2020
|
Invention
|
Short-chain fatty acid pentanoate as enhancer for cellular therapy and anti-tumor therapy. The in... |
|
|
Invention
|
Method and means for diagnosing a human sepsis. The present invention relates to a method of diag... |
|
|
Invention
|
Ultramodular igg3-based spacer domain and multi-function site for implementation in chimeric anti... |
|
|
Invention
|
Method for the detection and/or identification of magnetic supraparticles by means of magnetic pa... |
|
|
Invention
|
Compound and diagnostic system comprising said compound for the gustatory detection of inflammati... |
|
|
Invention
|
Use of an improved sleeping beauty transposase with increased solubility to facilitate and contro... |
|
|
Invention
|
Method and apparatus for manufacturing nanostructures from a material layer having a thickness be... |
|
2019
|
Invention
|
Aminomethyl-functionalized denatonium derivatives, their preparation and use. The present inventi... |
|
2018
|
Invention
|
Tumor necrosis factor (tnf) receptor superfamily (tnfrsf) receptor-activating antibody fusion pro... |
|
|
Invention
|
Control and modulation of the function of gene-modified chimeric antigen receptor t cells with da... |
|
|
Invention
|
Cd19cart cells eliminate myeloma cells that express very low levels of cd19. The invention genera... |
|
|
Invention
|
Use of flt3 car-t cells and flt3 inhibitors to treat acute myeloid leukemia. The invention genera... |
|
|
Invention
|
Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation. Th... |
|
|
Invention
|
Ror1-specific chimeric antigen receptors (car) with humanized targeting domains. The invention re... |
|
2017
|
Invention
|
Production of bitter principle derivatives. It is an object of the present invention to introduce... |
|
|
Invention
|
Compound comprising dexpanthenol. The invention relates to a compound characterised by a chemical... |
|
|
Invention
|
Glycosylated mono(2-hydroxyethyl) terephthalic acid and glycosylated bis(2-hydroxyethyl) terephth... |
|
2016
|
Invention
|
Soluble glycoprotein v for treating thrombotic diseases. A soluble polypeptide comprising a modif... |
|
|
Invention
|
Glycoprotein v inhibitors for use as coagulants. The present invention relates to an inhibitor of... |
|
|
Invention
|
Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoi... |
|
|
Invention
|
Gdf-15 as a diagnostic marker for melanoma. The present invention relates to methods for predicti... |
|
|
Invention
|
Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and i... |
|
|
Invention
|
A method for high level and stable gene transfer in lymphocytes. The method disclosed herein desc... |
|
2015
|
Invention
|
Monoclonal antibodies to growth and differentiation factor 15 (gdf-15), and uses thereof for trea... |
|
2013
|
Invention
|
Monoclonal antibodies to growth and differentiation factor 15 (gdf-15). The present invention rel... |
|
|
Invention
|
Radiopharmaceutical products for diagnosis and therapy of adrenal carcinoma. A radiopharmaceutica... |
|
|
Invention
|
Factor xii inhibitors for the treatment of neurological inflammatory disorders. This application ... |
|
|
Invention
|
Dual antigen-induced bipartite functional complementation. The present invention relates to a set... |
|
2010
|
Invention
|
Collagen fiber constructs for replacing cruciate ligaments.
The present invention relates to a c... |
|
|
Invention
|
Microrna-24. The present invention relates to a modulator, in particular an inhibitor, of microRN... |
|
|
Invention
|
Stim2-mediated capacitive calcium entry. The present invention relates to a pharmaceutical compos... |
|
|
Invention
|
Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab.... |
|
2009
|
Invention
|
The calcium sensor stim1 and the platelet soc channel orai1 (cracm1) are essential for pathologic... |
|
|
Invention
|
Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes. The present inve... |
|
2008
|
Invention
|
Compounds and markers for surface-enhanced raman scattering. The present invention relates to com... |
|
|
Invention
|
Mutant double cyclized receptor peptides inhibiting .beta.1-adrenoceptor antibodies. The present ... |
|
|
Invention
|
Bioceramic implants having bioactive substance. A bioceramic endoprosthesis includes a reservoir ... |
|
2007
|
Invention
|
Methods for increasing shoot-to-root ratio, seed production and resistance to diseases. The prese... |
|
|
Invention
|
C-terminal exon 5.4 of runx1/aml1. The present invention relates to a novel C-terminal exon of RU... |
|
2006
|
Invention
|
Tripeptides that down regulate the activity of plasma membrane transporters including sodium-d-gl... |
